Načítá se...
Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
BACKGROUND: Prostate cancer screening incurs a high risk of overdiagnosis and overtreatment. An organized and age‐targeted screening strategy may reduce the associated harms while retaining or enhancing the benefits. METHODS: Using a micro‐simulation analysis (MISCAN) model, we assessed the harms, b...
Uloženo v:
| Vydáno v: | Cancer Med |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7571827/ https://ncbi.nlm.nih.gov/pubmed/32813910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3395 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|